How are polynucleotide molecules defined by their nucleic acid sequence treated in patent applications?
Polynucleotide molecules defined by their nucleic acid sequence, also known as nucleotide sequences, are treated as structurally distinct chemical compounds in patent applications. According to MPEP 803.04: “Polynucleotide molecules defined by their nucleic acid sequence (hereinafter “nucleotide sequences”) that encode different proteins are structurally distinct chemical compounds. These sequences are thus deemed to normally constitute…
Read More